JTC-801
 | |
| Systematic (IUPAC) name | |
|---|---|
|
N-(4-amino-2-methylquinolin-6-yl)-2-[(4-ethylphenoxy)methyl]benzamide | |
| Identifiers | |
| CAS Number |
244218-51-7  |
| PubChem | CID 5311340 |
| IUPHAR/BPS | 1692 |
| ChemSpider |
4470841  |
| Synonyms | JTC-801 |
| Chemical data | |
| Formula | C26H25N3O2 |
| Molar mass | 411.51 g/mol |
| |
| |
| (what is this?) (verify) | |
JTC-801 is an opioid analgesic drug used in scientific research.[1][2]
JTC-801 is a selective antagonist for the nociceptin receptor, also known as the ORL-1 receptor.[3] This was the fourth opioid receptor to be discovered, and is still the least understood. The noiciceptin receptor has complex effects which are involved in many processes involved in pain and inflammation responses, and activation of this receptor can either increase or reduce pain depending on dose.[4] Drugs acting at the noiciceptin receptor may influence the effects of traditional analgesics such as NSAIDs,[5] μ-opioid agonists,[6] and cannabinoids.[7]
JTC-801 is an orally active drug that blocks the nociceptin receptor and produces analgesic effects in a variety of animal studies, and is particularly useful for neuropathic pain and allodynia associated with nerve injury.[8][9][10]
See also
References
- ↑ Shinkai H, Ito T, Iida T, Kitao Y, Yamada H, Uchida I (2000). "4-Aminoquinolines: novel nociceptin antagonists with analgesic activity". Journal of Medical Chemistry 43 (24): 4667–77. doi:10.1021/jm0002073. PMID 11101358.
- ↑ Yamada H, Nakamoto H, Suzuki Y, Ito T, Aisaka K (2002). "Pharmacological profiles of a novel opioid receptor-like1 (ORL1) receptor antagonist, JTC-801". British Journal of Pharmacology 135 (2): 323–32. doi:10.1038/sj.bjp.0704478. PMC 1573142. PMID 11815367.
- ↑ Sestili I, Borioni A, Mustazza C, Rodomonte A, Turchetto L, Sbraccia M, Riitano D, Del Giudice MR (2004). "A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists". European Journal of Medicinal Chemistry 39 (12): 1047–57. doi:10.1016/j.ejmech.2004.09.009. PMID 15571866.
- ↑ Muratani T, Minami T, Enomoto U, Sakai M, Okuda-Ashitaka E, Kiyokane K, Mori H, Ito S (2002). "Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride". The Journal of Pharmacology and Experimental Therapeutics 303 (1): 424–30. doi:10.1124/jpet.102.036095. PMID 12235279.
- ↑ Okuda-Ashitaka E, Minami T, Matsumura S, Takeshima H, Reinscheid RK, Civelli O, Ito S (2006). "The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury". The European Journal of Neuroscience 23 (4): 995–1004. doi:10.1111/j.1460-9568.2006.04623.x. PMID 16519664.
- ↑ Zaveri N, Jiang F, Olsen C, Polgar W, Toll L (2005). "Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP". The AAPS Journal 7 (2): E345–52. doi:10.1208/aapsj070234. PMC 2750971. PMID 16353914.
- ↑ Rawls SM, Schroeder JA, Ding Z, Rodriguez T, Zaveri N (2007). "NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats". Neuropeptides 41 (4): 239–47. doi:10.1016/j.npep.2007.03.001. PMID 17512052.
- ↑ Mabuchi T, Matsumura S, Okuda-Ashitaka E, Kitano T, Kojima H, Nagano T, Minami T, Ito S (2003). "Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production". The European Journal of Neuroscience 17 (7): 1384–92. doi:10.1046/j.1460-9568.2003.02575.x. PMID 12713641.
- ↑ Suyama H, Kawamoto M, Gaus S, Yuge O (2003). "Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model". Neuroscience Letters 351 (3): 133–6. doi:10.1016/S0304-3940(03)00502-0. PMID 14623124.
- ↑ Tamai H, Sawamura S, Takeda K, Orii R, Hanaoka K (2005). "Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation". European Journal of Pharmacology 510 (3): 223–8. doi:10.1016/j.ejphar.2005.01.033. PMID 15763246.
This article is issued from Wikipedia - version of the Sunday, February 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.